|
1
|
Lagergren J and Lagergren P: Recent
developments in esophageal adenocarcinoma. CA Cancer J Clin.
63:232–248. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Yang P, Zhao J, Hou L, Yang L, Wu K and
Zhang L: Vitamin E succinate induces apoptosis via the PI3K/AKT
signaling pathways in EC109 esophageal cancer cells. Mol Med Rep.
14:1531–1537. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Brown LM, Devesa SS and Chow WH: Incidence
of adenocarcinoma of the esophagus among white Americans by sex,
stage, and age. J Natl Cancer Inst. 100:1184–1187. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
He J, Zhou M, Chen X, Yue D, Yang L, Qin
G, Zhang Z, Gao Q, Wang D, Zhang C, et al: Inhibition of SALL4
reduces tumorigenicity involving epithelial-mesenchymal transition
via Wnt/β-catenin pathway in esophageal squamous cell carcinoma. J
Exp Clin Cancer Res. 35:982016. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Jemal A, Bray F, Center MM, Ferlay J, Ward
E and Forman D: Global cancer statistics. CA Cancer J Clin.
61:69–90. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Mariette C, Robb WB, Piessen G and Adenis
A: Neoadjuvant chemoradiation in esophageal cancer. Lancet Oncol.
16:1008–1009. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Seiwert TY, Connell PP, Mauer AM, Hoffman
PC, George CM, Szeto L, Salgia R, Posther KE, Nguyen B, Haraf DJ
and Vokes EE: A phase I study of pemetrexed, carboplatin, and
concurrent radiotherapy in patients with locally advanced or
metastatic non-small cell lung or esophageal cancer. Clin Cancer
Res. 13:515–522. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Raizer JJ, Rademaker A, Evens AM, Rice L,
Schwartz M, Chandler JP, Getch CC, Tellez C and Grimm SA:
Pemetrexed in the treatment of relapsed/refractory primary central
nervous system lymphoma. Cancer. 118:3743–3748. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Zhang JP, Lee EQ, Nayak L, Doherty L,
Kesari S, Muzikansky A, Norden AD, Chen H, Wen PY and Drappatz J:
Retrospective study of pemetrexed as salvage therapy for central
nervous system lymphoma. J Neurooncol. 115:71–77. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Feng Y, Yang Y, Fan C, Di S, Hu W, Jiang
S, Li T, Ma Z, Chao D, Feng X, et al: Pterostilbene inhibits the
growth of human esophageal cancer cells by regulating endoplasmic
reticulum stress. Cell Physiol Biochem. 38:1226–1244. 2016.
View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Guo YX, Lin ZM, Wang MJ, Dong YW, Niu HM,
Young CY, Lou HX and Yuan HQ: Jungermannenone A and B induce ROS-
and cell cycle-dependent apoptosis in prostate cancer cells in
vitro. Acta Pharmacol Sin. 37:814–824. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Zhao X, Kong F, Wang L and Zhang H: c-FLIP
and the NOXA/Mcl-1 axis participate in the synergistic effect of
pemetrexed plus cisplatin in human choroidal melanoma cells. PLoS
One. 12:e01841352017. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Zhao X, Liu X and Su L: Parthenolide
induces apoptosis via TNFRSF10B and PMAIP1 pathways in human lung
cancer cells. J Exp Clin Cancer Res. 33:32014. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Liu X, Lv Z, Zou J, Liu X, Ma J, Wang J,
Sa N, Jing P and Xu W: Afatinib down-regulates MCL-1 expression
through the PERK-eIF2alpha-ATF4 axis and leads to apoptosis in head
and neck squamous cell carcinoma. Am J Cancer Res. 6:1708–1719.
2016.PubMed/NCBI
|
|
15
|
Hauck P, Chao BH, Litz J and Krystal GW:
Alterations in the Noxa/Mcl-1 axis determine sensitivity of small
cell lung cancer to the BH3 mimetic ABT-737. Mol Cancer Ther.
8:883–892. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Wang H, Yang Y, Chen H, Dan J, Cheng J,
Guo S, Sun X, Wang W, Ai Y, Li S, et al: The predominant pathway of
apoptosis in THP-1 macrophage-derived foam cells induced by
5-aminolevulinic acid-mediated sonodynamic therapy is the
mitochondria-caspase pathway despite the participation of
endoplasmic reticulum stress. Cell Physiol Biochem. 33:1789–1801.
2014. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Lee JH, Kwon EJ and Kim DH: Calumenin has
a role in the alleviation of ER stress in neonatal rat
cardiomyocytes. Biochem Biophys Res Commun. 439:327–332. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Chow SE, Kao CH, Liu YT, Cheng ML, Yang
YW, Huang YK, Hsu CC and Wang JS: Resveratrol induced ER expansion
and ER caspase-mediated apoptosis in human nasopharyngeal carcinoma
cells. Apoptosis. 19:527–541. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Su L, Liu G, Hao X, Zhong N, Zhong D, Liu
X and Singhal S: Death receptor 5 and cellular FLICE-inhibitory
protein regulate pemetrexed-induced apoptosis in human lung cancer
cells. Eur J Cancer. 47:2471–2478. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Qin L, Wang Z, Tao L and Wang Y: ER stress
negatively regulates AKT/TSC/mTOR pathway to enhance autophagy.
Autophagy. 6:239–247. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Zeng H, Zheng R, Zhang S, Zuo T, Xia C,
Zou X and Chen W: Esophageal cancer statistics in China, 2011:
Estimates based on 177 cancer registries. Thorac Cancer. 7:232–237.
2016. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Chen W, Zheng R, Baade PD, Zhang S, Zeng
H, Bray F, Jemal A, Yu XQ and He J: Cancer statistics in China,
2015. CA Cancer J Clin. 66:115–132. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Quanjun D, Qingyu Z, Qiliang Z, Liqun X,
Jinmei C, Ziquan L and Shike H: Effect and mechanism of PAR-2 on
the proliferation of esophageal cancer cells. Eur Rev Med Pharmacol
Sci. 20:4688–4696. 2016.PubMed/NCBI
|
|
24
|
Ma YC, Ke Y, Zi X, Zhao F, Yuan L, Zhu YL,
Fan XX, Zhao NM, Li QY, Qin YH and Liu HM: Induction of the
mitochondria-mediated apoptosis in human esophageal cancer cells by
DS2, a newly synthetic diterpenoid analog, is regulated by Bax and
caused by generation of reactive oxygen species. Oncotarget.
7:86211–86224. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Sun Y, Wang Y, Han S, Xing B, Li H, Zhu Y,
Zhou S, Wang X, Xu J and Tao R: Efficacy and safety of pemetrexed
on recurrent primary central nervous system lymphomas in China: A
prospective study. Onco Targets Ther. 10:2595–2600. 2017.
View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Bolukbas S, Manegold C, Eberlein M,
Bergmann T, Fisseler-Eckhoff A and Schirren J: Survival after
trimodality therapy for malignant pleural mesothelioma: Radical
Pleurectomy, chemotherapy with Cisplatin/Pemetrexed and
radiotherapy. Lung Cancer. 71:75–81. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Yang JC, Hirsh V, Schuler M, Yamamoto N,
O'Byrne KJ, Mok TS, Zazulina V, Shahidi M, Lungershausen J, Massey
D, et al: Symptom control and quality of life in LUX-Lung 3: A
phase III study of afatinib or cisplatin/pemetrexed in patients
with advanced lung adenocarcinoma with EGFR mutations. J Clin
Oncol. 31:3342–3350. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Wang H, Liu Z, Gou Y, Qin Y, Xu Y, Liu J
and Wu JZ: Apoptosis and necrosis induced by novel realgar quantum
dots in human endometrial cancer cells via endoplasmic reticulum
stress signaling pathway. Int J Nanomedicine. 10:5505–5512. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Arakawa S, Nakanomyo I, Kudo-Sakamoto Y,
Akazawa H, Komuro I and Shimizu S: Identification of a novel
compound that inhibits both mitochondria-mediated necrosis and
apoptosis. Biochem Biophys Res Commun. 467:1006–1011. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Xu L, Su L and Liu X: PKCδ regulates death
receptor 5 expression induced by PS-341 through ATF4-ATF3/CHOP axis
in human lung cancer cells. Mol Cancer Ther. 11:2174–2182. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Wolfgang CD, Chen BP, Martindale JL,
Holbrook NJ and Hai T: Gadd153/Chop10, a potential target gene of
the transcriptional repressor ATF3. Mol Cell Biol. 17:6700–6707.
1997. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Liu G, Su L, Hao X, Zhong N, Zhong D,
Singhal S and Liu X: Salermide up-regulates death receptor 5
expression through the ATF4-ATF3-CHOP axis and leads to apoptosis
in human cancer cells. J Cell Mol Med. 16:1618–1628. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Tan H, Zhang H, Xie J, Chen B, Wen C, Guo
X, Zhao Q, Wu Z, Shen J, Wu J, et al: A novel staging model to
classify esophageal squamous cell carcinoma patients in China. Br J
Cancer. 110:2109–2115. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Xie JJ, Xie YM, Chen B, Pan F, Guo JC,
Zhao Q, Shen JH, Wu ZY, Wu JY, Xu LY and Li EM: ATF3 functions as a
novel tumor suppressor with prognostic significance in esophageal
squamous cell carcinoma. Oncotarget. 5:8569–8582. 2014. View Article : Google Scholar : PubMed/NCBI
|
